MELATONIN (MELATL07959)

DRUG2 trials

Sponsors

Sanofi, Bangladesh Medical University

Conditions

Parkinson DiseaseSleep Disorder (Healthy Volunteers)

Phase 1

Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders

CompletedNCT03514732

SanofiSleep Disorder (Healthy Volunteers)

Start: 2017-03-17End: 2017-07-05Updated: 2022-04-25

Phase 2

Effect of Melatonin on Oxidative Stress Parameters in Levodopa-Treated Parkinson's Disease Patients

Enrolling by invitationNCT07375693

Bangladesh Medical UniversityParkinson Disease

Start: 2026-02-17End: 2026-09-15Target: 70Updated: 2026-01-29